Immatics (IMTX) Total Non-Current Liabilities (2019 - 2025)

Immatics' (IMTX) quarterly Total Non-Current Liabilities came in at $41.0 million in Q4 2025, down 28.03% year-on-year from $57.0 million in Q4 2024, and down 11.47% quarter-over-quarter from $46.3 million in Q3 2025.

Immatics (IMTX) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends

Immatics has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $41.0 million for Q4 2025.

  • Total Non-Current Liabilities for Q4 2025 came in at $41.0 million, down 28.03% year-over-year; the trailing twelve-month figure through Dec 2025 was $41.0 million (down 28.03% YoY), and the FY2025 annual result was $39.8 million, down 30.15% from the prior year.
  • Total Non-Current Liabilities came in at $41.0 million for Q4 2025 at Immatics, down from $46.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $146.1 million in Q4 2023 to a low of $41.0 million in Q4 2025.
  • The 5-year median for Total Non-Current Liabilities is $78.3 million (2021), against an average of $83.3 million.
  • Across the five-year window, Total Non-Current Liabilities soared 76.84% in 2022 and plunged 61.01% in 2024, its largest moves.
  • Immatics' Total Non-Current Liabilities stood at $63.4 million in 2021, then soared by 57.69% to $100.0 million in 2022, then soared by 46.11% to $146.1 million in 2023, then plunged by 61.01% to $57.0 million in 2024, then slipped by 28.03% to $41.0 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $41.0 million (Q4 2025), $46.3 million (Q3 2025), and $51.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Immatics 14.67 Bn 14.67 Bn - 41.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 41.00 Mn
Sep 30, 2025 46.32 Mn
Jun 30, 2025 51.48 Mn
Mar 31, 2025 51.87 Mn
Dec 31, 2024 56.97 Mn
Sep 30, 2024 75.95 Mn
Jun 30, 2024 103.55 Mn
Mar 31, 2024 119.38 Mn
Dec 31, 2023 146.11 Mn
Sep 30, 2023 74.62 Mn
Jun 30, 2023 73.69 Mn
Mar 31, 2023 83.53 Mn
Dec 31, 2022 100.00 Mn
Sep 30, 2022 118.10 Mn
Jun 30, 2022 138.04 Mn
Mar 31, 2022 83.44 Mn
Dec 31, 2021 63.42 Mn
Sep 30, 2021 66.78 Mn
Jun 30, 2021 80.61 Mn
Mar 31, 2021 91.77 Mn